12-month longitudinal cognitive functioning in patients recently diagnosed with bipolar disorder

Bipolar Disorders

Volumn 16, Issue 2, 2014, Pages 159-171

  Torres, Ivan J ^a,b   Kozicky, Jan ^a   Popuri, Swetha ^a   Bond, David J ^a   Honer, William G ^a,b   Lam, Raymond W ^a   Yatham, Lakshmi N ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b British Columbia Mental Health Addiction Services   (Canada)

Author keywords

Antipsychotic; Cognitive; Executive function; Longitudinal; Mania; Memory; Neurocognition; Neuropsychology; Substance abuse

Indexed keywords

LAMOTRIGINE; LITHIUM; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROATE SEMISODIUM;

ADULT; ALCOHOL ABUSE; ARTICLE; ATTENTION; BIPOLAR DISORDER; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIXED MANIA AND DEPRESSION; MOOD CHANGE; NEUROPSYCHOLOGY; NONVERBAL MEMORY; PRIORITY JOURNAL; PROCESSING SPEED; SUBSTANCE ABUSE; VERBAL MEMORY; WORKING MEMORY;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; ATTENTION; BIPOLAR DISORDER; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; TIME FACTORS; VERBAL LEARNING; YOUNG ADULT;

EID: 84896705577     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12154     Document Type: Article

References (64)

1. Torres IJ, Defreitas VG, Defreitas CM et al. Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode. J Clin Psychiatry 2010; 71: 1234-1242.
2. Bora E, Yucel M, Pantelis C. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord 2009; 113: 1-20.
3. Gildengers AG, Mulsant BH, Begley A et al. The longitudinal course of cognition in older adults with bipolar disorder. Bipolar Disord 2009; 11: 744-752.
4. Arts B, Jabben N, Krabbendam L, van Os J. A 2-year naturalistic study on cognitive functioning in bipolar disorder. Acta Psychiatr Scand 2011; 123: 190-205.
5. Depp CA, Savla GN, Moore DJ et al. Short-term course of neuropsychological abilities in middle-aged and older adults with bipolar disorder. Bipolar Disord 2008; 10: 684-690.
6. Moorhead TW, McKirdy J, Sussmann JE et al. Progressive gray matter loss in patients with bipolar disorder. Biol Psychiatry 2007; 62: 894-900.
7. Mur M, Portella MJ, Martinez-Aran A, Pifarre J, Vieta E. Neuropsychological profile in bipolar disorder: a preliminary study of monotherapy lithium-treated euthymic bipolar patients evaluated at a 2-year interval. Acta Psychiatr Scand 2008; 118: 373-381.
8. Mur M, Portella MJ, Martinez-Aran A, Pifarre J, Vieta E. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients. J Clin Psychiatry 2008; 69: 712-719.
9. Delaloye C, Moy G, de Bilbao F et al. Longitudinal analysis of cognitive performances and structural brain changes in late-life bipolar disorder. Int J Geriatr Psychiatry 2011; 26: 1309-1318.
10. Hill SK, Reilly JL, Harris MS et al. A comparison of neuropsychological dysfunction in first-episode psychosis patients with unipolar depression, bipolar disorder, and schizophrenia. Schizophr Res 2009; 113: 167-175.
11. Zanelli J, Reichenberg A, Morgan K et al. Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations. Am J Psychiatry 2010; 167: 78-85.
12. Vieta E, Reinares M, Rosa AR. Staging bipolar disorder. Neurotox Res 2011; 19: 279-285.
13. Berk M, Kapczinski F, Andreazza AC et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011; 35: 804-817.
14. Kapczinski F, Vieta E, Andreazza AC et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev 2008; 32: 675-692.
15. Post RM. Mechanisms of illness progression in the recurrent affective disorders. Neurotox Res 2010; 18: 256-271.
16. Torres IJ, DeFreitas CM, DeFreitas VG et al. Relationship between cognitive functioning and 6-month clinical and functional outcome in patients with first manic episode bipolar I disorder. Psychol Med 2011; 41: 971-982.
17. Yatham LN, Kauer-Sant'Anna M, Bond DJ, Lam RW, Torres I. Course and outcome after the first manic episode in patients with bipolar disorder: prospective 12-month data from the systematic treatment optimization program for early mania project. Can J Psychiatry 2009; 54: 105-112.
18. Sheehan DV, Lecrubier Y, Sheehan KH et al. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 (Suppl. 20): 22-33.
19. Torres IJ, Boudreau VG, Yatham LN. Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand 2007; 116 (Suppl. 434): 17-26.
20. Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, Rabbitt P. Cambridge neuropsychological test automated battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia 1994; 5: 266-281.
21. Nuechterlein KH, Green MF, Kern RS et al. The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity. Am J Psychiatry 2008; 165: 203-213.
22. Yatham LN, Torres IJ, Malhi GS et al. The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC). Bipolar Disord 2010; 12: 351-363.
23. Burdick KE, Goldberg TE, Cornblatt BA et al. The MATRICS consensus cognitive battery in patients with bipolar I disorder. Neuropsychopharmacology 2011; 36: 1587-1592.
24. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery. Tucson, AZ: Neuropsychology Press, 1985.
25. Lezak MD. Neuropsychological Assessment, 2nd edn. New York, NY: Oxford University Press, 2004.
26. Golden CJ, Freshwater SM. A Manual for the Adult Stroop Color and Word Test. Chicago, IL: Stoelting, 2002.
27. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophr Res 2004; 72: 29-39.
28. Czobor P, Jaeger J, Berns SM, Gonzalez C, Loftus S. Neuropsychological symptom dimensions in bipolar disorder and schizophrenia. Bipolar Disord 2007; 9: 71-92.
29. Clark L, Iversen SD, Goodwin GM. Sustained attention deficit in bipolar disorder. Br J Psychiatry 2002; 180: 313-319.
30. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test, Second Edition, Adult Version. San Antonio, TX: The Psychological Corporation, 2000.
31. Robbins TW, James M, Owen AM et al. A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: implications for theories of executive functioning and cognitive aging. Cambridge Neuropsychological Test Automated Battery. J Int Neuropsychol Soc 1998; 4: 474-490.
32. Wechsler D. The Wechsler Memory Scale-III manual. San Antonio, TX: The Psychological Corporation, 1997.
33. Strauss E, Sherman EMS, Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary, 3rd edn. New York, NY: Oxford University Press, 2006.
34. Lehto JE, Juujärvi P, Kooistra L, Pulkkinen L. Dimensions of executive functioning: evidence from children. Br J Dev Psychol 2003; 21: 59-80.
35. Stuss DT, Levine B. Adult clinical neuropsychology: lessons from studies of the frontal lobes. Annu Rev Psychol 2002; 53: 401-433.
36. Delis DC, Kaplan E, Kramer JH. Delis-Kaplan Executive Function System. San Antonio, TX: The Psychological Corporation, 2001.
37. de Frias CM, Dixon RA, Strauss E. Structure of four executive functioning tests in healthy older adults. Neuropsychology 2006; 20: 206-214.
38. Yatham LN, Kennedy SH, Schaffer A et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 2009; 11: 225-255.
39. Kaufman AS, Kaufman NL. Kaufman Brief Intelligence Test Manual. Circle Pines, MN: American Guidance Service, 1990.
40. Blair JR, Spreen O. Predicting premorbid IQ: a revision of the national adult reading test. Clin Neuropsychol 1989; 3: 129-136.
41. Heck RH, Thomas SL, Tabata LN. Multilevel and Longitudinal Modeling with IBM SPSS: Quantitative Methodology Series. New York, NY: Routledge, 2010.
42. Horn K, Roessner V, Holtmann M. Neurocognitive performance in children and adolescents with bipolar disorder: a review. Eur Child Adolesc Psychiatry 2011; 20: 433-450.
43. Senturk V, Goker C, Bilgic A et al. Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate. Bipolar Disord 2007; 9 (Suppl. 1): 136-144.
44. Delaloye C, de Bilbao F, Moy G et al. Neuroanatomical and neuropsychological features of euthymic patients with bipolar disorder. Am J Geriatr Psychiatry 2009; 17: 1012-1021.
45. Kulkarni S, Jain S, Janardhan Reddy YC, Kumar KJ, Kandavel T. Impairment of verbal learning and memory and executive function in unaffected siblings of probands with bipolar disorder. Bipolar Disord 2010; 12: 647-656.
46. Quraishi S, Walshe M, McDonald C et al. Memory functioning in familial bipolar I disorder patients and their relatives. Bipolar Disord 2009; 11: 209-214.
47. Balanza-Martinez V, Rubio C, Selva-Vera G et al. Neurocognitive endophenotypes (endophenocognitypes) from studies of relatives of bipolar disorder subjects: a systematic review. Neurosci Biobehav Rev 2008; 32: 1426-1438.
48. Savitz JB, van der Merwe L, Stein DJ, Solms M, Ramesar RS. Neuropsychological task performance in bipolar spectrum illness: genetics, alcohol abuse, medication and childhood trauma. Bipolar Disord 2008; 10: 479-494.
49. Levy B, Manove E. Functional outcome in bipolar disorder: the big picture. Depress Res Treat 2012; 2012: 949248.
50. Wingo AP, Harvey PD, Baldessarini RJ. Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disord 2009; 11: 113-125.
51. Levy B, Monzani BA, Stephansky MR, Weiss RD. Neurocognitive impairment in patients with co-occurring bipolar disorder and alcohol dependence upon discharge from inpatient care. Psychiatry Res 2008; 161: 28-35.
52. Sanchez-Moreno J, Martinez-Aran A, Colom F et al. Neurocognitive dysfunctions in euthymic bipolar patients with and without prior history of alcohol use. J Clin Psychiatry 2009; 70: 1120-1127.
53. Shan C, Lee SY, Chang YH et al. Neuropsychological functions in Han Chinese patients in Taiwan with bipolar II disorder comorbid and not comorbid with alcohol abuse/alcohol dependence disorder. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 131-136.
54. van Gorp WG, Altshuler L, Theberge DC, Wilkins J, Dixon W. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. Arch Gen Psychiatry 1998; 55: 41-46.
55. Ringen PA, Vaskinn A, Sundet K et al. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia. Psychol Med 2010; 40: 1337-1347.
56. van der Werf-Eldering MJ, Burger H, Holthausen EA, Aleman A, Nolen WA. Cognitive functioning in patients with bipolar disorder: association with depressive symptoms and alcohol use. PLoS ONE 2010; 5: e13032.
57. Kozicky JM, Torres IJ, Bond DJ, Lam RW, Yatham LN. Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar I disorder. Int Clin Psychopharmacol 2012; 27: 91-99.
58. Torrent C, Martinez-Aran A, Daban C et al. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients. Compr Psychiatry 2011; 52: 613-622.
59. Faber G, Smid HG, Van Gool AR, Wiersma D, Van Den Bosch RJ. The effects of guided discontinuation of antipsychotics on neurocognition in first onset psychosis. Eur Psychiatry 2012; 27: 275-280.
60. Yasuda S, Liang MH, Marinova Z, Yahyavi A, Chuang DM. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psychiatry 2009; 14: 51-59.
61. Gualtieri CT, Johnson LG. Comparative neurocognitive effects of 5 psychotropic anticonvulsants and lithium. MedGenMed 2006; 8: 46-46.
62. Wingo AP, Wingo TS, Harvey PD, Baldessarini RJ. Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry 2009; 70: 1588-1597.
63. Judd LL, Akiskal HS, Schettler PJ et al. Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Arch Gen Psychiatry 2005; 62: 1322-1330.
64. Schwartz S, Susser E. The use of well controls: an unhealthy practice in psychiatric research. Psychol Med 2011; 41: 1127-1131.